Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PLUR | US
-0.14
-2.85%
Healthcare
Biotechnology
30/06/2024
17/10/2024
4.81
4.84
4.88
4.54
Pluri Inc. a biotechnology company focuses on the development of placenta-based cell therapy product candidates for the treatment of inflammatory muscle injuries and hematologic conditions. The company develops placental expanded (PLX) based cell therapy products including PLX-PAD that is in Phase III clinical trial for the muscle recovery following surgery for hip fracture; and Phase I/II clinical trial for the treatment of steroid-refractory graft versus host disease in collaboration with Tel Aviv Sourasky Medical Center as well as completed a Phase II clinical trial for the treatment of acute respiratory distress syndrome associated with COVID-19 and a Phase I clinical trial for incomplete recovery following bone marrow transplantation. It also develops PLX-R18 for incomplete hematopoietic recovery following hematopoietic cell transplantation; and a solution for the treatment of acute radiation syndrome through its collaboration in the United States with the National Institutes of Health and the U.S. Department of Defense. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa Israel.
View LessNegative Momentum (Declining Price)
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
76.5%1 month
86.8%3 months
65.9%6 months
68.4%-
-
260.40
308.46
0.75
-1.28
75.54
-
-21.91M
26.31M
26.31M
-
-6.29K
-
-13.50
-206.07
0.46
0.12
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.89
Range1M
1.66
Range3M
1.66
Rel. volume
0.96
Price X volume
82.12K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
ImmuCell Corporation | ICCC | Biotechnology | 3.625 | 28.39M | 1.83% | n/a | 67.52% |
Kala Pharmaceuticals Inc | KALA | Biotechnology | 5.1119 | 28.02M | -2.82% | n/a | 268.29% |
Mawson Infrastructure Group Inc. Common Stock | MIGI | Biotechnology | 1.45 | 26.90M | -0.68% | n/a | 571.64% |
Akari Therapeutics Plc | AKTX | Biotechnology | 2.21 | 26.84M | -12.30% | n/a | -27.01% |
Common Stock | NRBO | Biotechnology | 3.16 | 26.82M | 6.76% | n/a | 0.90% |
SABS | SABS | Biotechnology | 2.76 | 25.47M | -11.25% | n/a | 11.58% |
Tonix Pharmaceuticals Holding Corp | TNXP | Biotechnology | 0.1794 | 25.11M | 12.83% | n/a | 21.99% |
Iterum Therapeutics plc | ITRM | Biotechnology | 1.09 | 24.75M | 5.83% | n/a | -198.11% |
iBio Inc | IBIO | Biotechnology | 2.85 | 24.62M | 0.00% | n/a | 20.92% |
CytoMed Therapeutics Limited Ordinary Shares | GDTC | Biotechnology | 2.1301 | 24.58M | 2.41% | n/a | 3.98% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 12.6 | 19.19M | 0.80% | n/a | 204.46% |
ILAG | ILAG | Building Products & Equipment | 0.98 | 17.70M | -3.92% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5763 | 8.36M | -11.91% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2111 | 3.79M | 2.93% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.04 | 2.71M | -4.59% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0114 | 1.02M | 14.00% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.16 | 0 | -0.43% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.3 | 0 | 2.14% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.535 | 0 | 7.00% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.07 | 0 | 1.90% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -1.28 | 0.53 | Cheaper |
Ent. to Revenue | 75.54 | 4,005.99 | Cheaper |
PE Ratio | - | 40.42 | - |
Price to Book | 260.40 | 15.30 | Expensive |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 65.88 | 72.92 | Par |
Debt to Equity | 308.46 | -1.24 | Expensive |
Debt to Assets | 0.75 | 0.25 | Expensive |
Market Cap | 26.31M | 3.78B | Emerging |